PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Optimal Warfarin Management for Prevention of Thromboembolic Events in Patients with Atrial Fibrillation [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Nov. (CADTH Optimal Use Report, No. 1.2.)


Menke J, Luthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol. 2010 Feb 15;105(4):502–510. [PubMed: 20152245]
Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010 Jul;123(7):638–645. [PubMed: 20609686]
Marinigh R, Lip GYH, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol. 2010;56(11):827–837. [PubMed: 20813280]
Savelieva I, Bajpai A, Camm AJ. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Ann Med. 2007;39(5):371–391. [PubMed: 17701479]
Hankey GJ. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs? Curr Opin Neurol. 2010 Feb;23(1):65–72. [PubMed: 19949330]
du Breuil AL, Umland EM. Outpatient management of anticoagulation therapy. Am Fam Physician. 2007 Apr 1;75(7):1031–1042. [PubMed: 17427618]
Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest. 2008 Jun;133(6 Suppl):160S–198S. [PubMed: 18574265]
Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M.CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol [Internet] Jan, 2011. [cited 2011 May 18]. pp. 74–90. Available from: http://www​.onlinecjc​.ca/article/S0828-282X(10)00008-5​/fulltext. [PubMed: 21329865]
Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost [Internet] Mar 1, 1993. [cited 2011 May 12]. pp. 236–239. Available from: https://openaccess​.leidenuniv​.nl/bitstream​/1887/1793/1/303_324.pdf. [PubMed: 8470047]
Tsuyuki RT, Bungard T, Grant CM, Ackman ML. Anticoagulation clinics in North America: operational insights. Can J Hosp Pharm. 2008 Jul;61(4):245–246.
Poon IO, Lal L, Brown EN, Braun UK. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther. 2007 Feb;32(1):21–29. [PubMed: 17286786]
Ansell J, Hollowell J, Pengo V, Martinez-Brotons F, Caro J, Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM) J Thromb Thrombolysis. 2007 Apr;23(2):83–91. [PubMed: 17221328]
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol [Internet] 2007. [cited 2011 Jul 14]. p. 10. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC1810543. [PMC free article: PMC1810543] [PubMed: 17302989]
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health [Internet] Jun, 1998. [cited 2011 Jul 14]. pp. 377–384. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles​/PMC1756728/pdf/v052p00377.pdf. [PMC free article: PMC1756728] [PubMed: 9764259]
Aziz F, Corder M, Wolffe J, Comerota AJ. Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care. J Vasc Surg. 2011 Jul 7 Epub ahead of print. [PubMed: 21741791]
Garton L, Crosby JF. A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability. J Thromb Thrombolysis. 2011 Nov;32(4):426–430. [PubMed: 21710189]
Hall D, Buchanan J, Helms B, Eberts M, Mark S, Manolis C, et al. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care. Pharmacotherapy. 2011 Jul;31(7):686–694. [PubMed: 21923456]
Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010 Apr;30(4):330–338. [PubMed: 20334453]
Garwood CL, Dumo P, Baringhaus SN, Laban KM. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy. Pharmacotherapy. 2008 Jan;28(1):20–26. [PubMed: 18154470]
Fitzmaurice DA. Oral anticoagulation control: The European perspective. J Thromb Thrombolysis. 2006 Feb;21(1):95–100. [PubMed: 16475050]
Edgeworth A, Coles EC. An evaluation of near-patient testing of anticoagulant control in general practice. Int J Health Care Qual Assur. 2010;23(4):410–421. [PubMed: 20535909]
Christensen H, Lauterlein JJ, Sorensen PD, Petersen ER, Madsen JS, Brandslund I. Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemed J E Health. 2011 Apr;17(3):169–176. [PMC free article: PMC3079164] [PubMed: 21254841]
McCahon D, Murray ET, Murray K, Holder RL, Fitzmaurice DA. Does self-management of oral anticoagulation therapy improve quality of life and anxiety? Fam Pract. 2011 Apr;28(2):134–140. [PubMed: 21068191]
Gardiner C, Longair I, Pescott MA, Erwin H, Hills J, Machin SJ, et al. Self-monitoring of oral anticoagulation: does it work outside trial conditions? J Clin Pathol [Internet] Feb, 2009. [cited 2011 Jun 3]. pp. 168–171. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC2629005. [PMC free article: PMC2629005] [PubMed: 19181634]
O'Shea SI, Arcasoy MO, Samsa G, Cummings SE, Thames EH, Surwit RS, et al. Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation. J Thromb Thrombolysis. 2008 Aug;26(1):14–21. [PubMed: 17616845]
McCahon D, Murray ET, Jowett S, Sandhar HS, Holder RL, Hussain S, et al. Patient self management of oral anticoagulation in routine care in the UK. J Clin Pathol [Internet] Nov, 2007. [cited 2011 Jun 13]. pp. 1263–1267. Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC2095473. [PMC free article: PMC2095473] [PubMed: 17259295]
Harper P, Pollock D. Improved anticoagulant control in patients using home international normalized ratio testing and decision support provided through the internet. Intern Med J. 2011 Apr;41(4):332–337. [PubMed: 20546057]
Salvador CH, Ruiz-Sanchez A, Gonzalez de Mingo MA, Carmona RM, Carrasco MP, Sagredo PG, et al. Evaluation of a telemedicine-based service for the follow-up and monitoring of patients treated with oral anticoagulant therapy. IEEE Trans Inf Technol Biomed. 2008 Nov;12(6):696–706. [PubMed: 19000948]
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, et al. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Thromb Haemost. 2009 Mar;101(3):487–494. [PubMed: 19277410]
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, et al. A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage. Br J Haematol [Internet] Oct, 2008. [cited 2011 Jun 13]. pp. 274–283. Available from: http:​//onlinelibrary​​.1365-2141.2008.07337.x/pdf. [PubMed: 18759767]
Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, et al. An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost. 2008 Jun;6(6):935–943. [PubMed: 18489430]
Onundarson PT, Einarsdottir KA, Gudmundsdottir BR. Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice. Int J Lab Hematol. 2008 Oct;30(5):382–389. [PubMed: 19046313]
Bloomfield HE, Taylor BC, Krause A, Reddy P, Greer N, MacDonald R, et al. Safe and effective anticoagulation in the outpatient setting: a systematic review of the evidence [Internet] Washington (DC): Department of Veterans Affairs (US); Feb, 2011. [cited 2011 May 31]. (VA-ESP Project #09-009). Available from: http://www​.ncbi.nlm.nih​.gov/books/NBK54599/ [PubMed: 21595123]
Saokaew S, Permsuwan U, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A. Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis. J Thromb Thrombolysis. 2010 Nov;8(11):2418–2427. [PubMed: 20831620]
Cios DA, Baker WL, Sander SD, Phung OJ, Coleman CI. Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis. Am J Health Syst Pharm. 2009 May 15;66(10):916–925. [PubMed: 19420310]
Baker WL, Cios DA, Sander SD, Coleman CI. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm [Internet] Apr, 2009. [cited 2011 May 12]. pp. 244–252. Available from: http://www​​.pdf. [PubMed: 19326955]
Dolan G, Smith LA, Collins S, Plumb JM. Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature. Curr Med Res Opin. 2008 May;24(5):1459–1472. [PubMed: 18402715]
van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest [Internet] May, 2006. [cited 2011 May 12]. pp. 1155–1166. Available from: http://chestjournal​.chestpubs​.org/content/129/5/1155​.full.pdf+html. [PubMed: 16685005]
Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev. 2010;(4):CD003839. [PubMed: 20393937]
Wells PS, Brown A, Jaffey J, McGahan L, Poon MC, Cimon K. Safety and effectiveness of point-of-care monitoring devices in patients on oral anticoagulant therapy: a meta-analysis. Open Med [Internet] 2007. [cited 2011 Jun 20]. pp. e131–e146. Available from: http://www​.openmedicine​.ca/article/view/77/75. [PMC free article: PMC3113217] [PubMed: 21673942]
Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess [Internet] Oct, 2007. [cited 2011 May 12]. pp. iii–66. Available from: http://www​ [PubMed: 17903392]
Bloomfield HE, Krause A, Greer N, Taylor BC, MacDonald R, Rutks I, et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med. 2011 Apr 5;154(7):472–482. [PubMed: 21464349]
Copyright © 2011 CADTH.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at

Cover of Optimal Warfarin Management for Prevention of Thromboembolic Events in Patients with Atrial Fibrillation
Optimal Warfarin Management for Prevention of Thromboembolic Events in Patients with Atrial Fibrillation [Internet].
CADTH Optimal Use Report, No. 1.2.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...